Study: Diabetes Drug Has Potential Value For Treating TBI

Categories: Uncategorized

New research shows that a drug approved for the treatment of diabetes may be valuable to victims of traumatic brain injury (TBI). Exendin-4 is currently approved by the U.S. Food and Drug Administration (FDA) for use by diabetics but its spectrum of medical value may be much broader, according to research conducted by the U.S. Air Force, Tel Aviv University and the National Institute of Aging.

Exendin-4 has proved effective in minimizing damage from TBI in laboratory animals. Specifically, the drug helps protect brain cells when administered soon after the victim suffers a traumatic brain injury. Exendin-4 has already been earmarked as a tool for battling Alzheimer’s disease; the recent TBI study certainly solidifies the drug’s potential value in the medical world.

In the TBI study, scientists exposed laboratory rats to explosions. Rats that received Exendin-4 soon after suffering brain injury experienced a decrease in long-term TBI symptoms. Further studies are necessary, but hopefully there will be a profound increase in the medical community’s ability to treat brain injury victims.

If you or a loved one has suffered a brain injury from someone’s negligence – such as a car accident – contact a skilled Ohio head injury attorney to discuss your legal options.

Source: Bioresearch Online, “Diabetes Drug Could Be A Promising Therapy For Traumatic Brain Injury,” May 29, 2012


or Call Us: 800-792-1480